摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-allylguanidine hemisulfate | 54642-82-9

中文名称
——
中文别名
——
英文名称
1-allylguanidine hemisulfate
英文别名
allyl-guanidine; sulfate;Allyl-guanidin; Sulfat;1-Allylguanidine sulfate;2-prop-2-enylguanidine;sulfuric acid
1-allylguanidine hemisulfate化学式
CAS
54642-82-9
化学式
2C4H9N3*H2O4S
mdl
——
分子量
296.351
InChiKey
DBCXQYSTRDCROV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    208-210 °C

计算性质

  • 辛醇/水分配系数(LogP):
    -1.21
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    147
  • 氢给体数:
    4
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    二乙基-2-乙氧羰基庚二酸酯1-allylguanidine hemisulfatesodium hydroxidesodium methylate 作用下, 生成 5-(2-Allylamino-4-hydroxy-6-oxo-1,6-dihydro-pyrimidin-5-yl)-pentanoic acid
    参考文献:
    名称:
    Some 2-substitution derivatives of 5-(4-oxo-6-hydroxy-3,4-dihydro-5-pyrimidinyl)pentanoic acid
    摘要:
    三乙酸1,1,5-戊二酸酯(XI)与取代基胍(XXII - XXIX)的缩合反应产生了酸(II - IX),然后转化为酯(XI - XIX)。酸(II)和酯(XI)以位置异构体的混合物形式得到。类似地,三酯(XXI)与二氰二胍的缩合反应产生了酸(X),其腈基在酯化羧基的条件下形成亚胺醚(XX)。在抗肿瘤活性的药理学测试中,所制备的化合物表现出比作为标准的5-(2-氨基-6-羟基-4-氧代-3,4-二氢-5-嘧啶基)戊酸(I)更弱的效力。
    DOI:
    10.1135/cccc19830304
  • 作为产物:
    参考文献:
    名称:
    Some 2-substitution derivatives of 5-(4-oxo-6-hydroxy-3,4-dihydro-5-pyrimidinyl)pentanoic acid
    摘要:
    三乙酸1,1,5-戊二酸酯(XI)与取代基胍(XXII - XXIX)的缩合反应产生了酸(II - IX),然后转化为酯(XI - XIX)。酸(II)和酯(XI)以位置异构体的混合物形式得到。类似地,三酯(XXI)与二氰二胍的缩合反应产生了酸(X),其腈基在酯化羧基的条件下形成亚胺醚(XX)。在抗肿瘤活性的药理学测试中,所制备的化合物表现出比作为标准的5-(2-氨基-6-羟基-4-氧代-3,4-二氢-5-嘧啶基)戊酸(I)更弱的效力。
    DOI:
    10.1135/cccc19830304
点击查看最新优质反应信息

文献信息

  • KREPELKA, J.;BENES, J.;POUZAR, V.;VACHEK, J.;HOLUBEK, J., COLLECT. CZECH. CHEM. COMMUN., 1983, 48, N 1, 304-311
    作者:KREPELKA, J.、BENES, J.、POUZAR, V.、VACHEK, J.、HOLUBEK, J.
    DOI:——
    日期:——
  • Some 2-substitution derivatives of 5-(4-oxo-6-hydroxy-3,4-dihydro-5-pyrimidinyl)pentanoic acid
    作者:Jiří Křepelka、Jan Beneš、Vladimír Pouzar、Jaroslav Vachek、Jiří Holubek
    DOI:10.1135/cccc19830304
    日期:——

    Condensation of triethyl ester of 1,1,5-pentanetricarboxylic acid (XI) with substituted guanidines XXII - XXIX gave acids II - IX, which were converted into esters XI - XIX. The acid II and the ester XI were obtained as mixtures of positional isomers. Analogously, condensation of the triester XXI with dicyanodiamide gave rise to acid X, whose nitrile group, under conditions of esterification of a carboxyl group, produced iminoether XX. In pharmacological tests for antineoplastic activity the compounds prepared exhibited weaker efficacy than 5-(2-amino-6-hydroxy-4-oxo-3,4-dihydro-5-pyrimidinyl)pentanoic acid (I), employed as standard.

    三乙酸1,1,5-戊二酸酯(XI)与取代基胍(XXII - XXIX)的缩合反应产生了酸(II - IX),然后转化为酯(XI - XIX)。酸(II)和酯(XI)以位置异构体的混合物形式得到。类似地,三酯(XXI)与二氰二胍的缩合反应产生了酸(X),其腈基在酯化羧基的条件下形成亚胺醚(XX)。在抗肿瘤活性的药理学测试中,所制备的化合物表现出比作为标准的5-(2-氨基-6-羟基-4-氧代-3,4-二氢-5-嘧啶基)戊酸(I)更弱的效力。
  • Benzylguanidines and Other Galegine Analogues Inducing Weight Loss in Mice
    作者:Geoffrey D. Coxon、Brian L. Furman、Alan L. Harvey、John McTavish、Mark H. Mooney、Mahmoud Arastoo、Alan R. Kennedy、Justice M. Tettey、Roger D. Waigh
    DOI:10.1021/jm8011933
    日期:2009.6.11
    Dimethylallylguanidine, also known as galegine, isolated from Galega officinalis, has been shown to have weight reducing properties in vivo. Substitution of the guanidine group with an N-cyano group and replacement of guanidine with amidine, pyrimidine, pyridine, or the imidazole moieties removed the weight reducing properties when evaluated in BALB/c mice. However, retention of the guanidine and replacement of the dimethylallyl group by a series of functionalized benzyl substituents was shown to exhibit, and in some cases significantly improve, the weight reducing properties of these molecules in BALB/c, ob/ob, and diet induced obesity (DIO) mice models. The lead compound identified, across all models, was 1-(4-chlorobenzyl)guanidine hemisulfate, which gave an average daily weight difference (% from time-matched controls; +/- SEM) of -19.7 +/- 1.0, -11.0 +/- 0.7, and -7.3 +/- 0.8 in BALB/c, ob/ob, and DIO models, respectively.
查看更多